Knowledge and Attitude Regarding Pharmacovigilance in General Population
DOI:
https://doi.org/10.37506/b1v3yh30Keywords:
knowledge, attitude, public perception, ADR reporting, pharmacovigilanceAbstract
Background: Pharmacovigilance is a cornerstone of the healthcare system. As patients are the end users, their contribution to such programs is inevitable. The National Pharmacovigilance Program of India emphasizes the same and this study has been conducted in the light of these findings. The study aims to ascertain public opinion, knowledge, and awareness regarding pharmacovigilance.
Methods: A cross-sectional study was conducted using a validated questionnaire in the form of an online and offline survey of the general population. A convenience sampling technique was used and data collection and analysis were done.
Results: Amongst the total 663 responses - 89% knew that drugs can have both beneficial and adverse effects, yet only 54% of them were aware of various drug adverse effects. A meagre 1% and 5% were aware of reporting them to the Adverse Event Monitoring Centre and banned drugs respectively. About 60% of participants believe that reporting adverse reactions is the responsibility of medical personnel only. Factors like lower education status, and rural setting were statistically significantly associated with study aspects like -lesser ADR reporting and poor knowledge of banned drugs.
Conclusion: The general population needs sensitization as regards ADR reporting and pharmacovigilance given patient safety and healthcare empowerment.
References
Geneva: World Health Organization. Looking at the Pharmacovigilance: ensuring the safe use of medicines. WHO Policy Perspectives on Medicines. Geneva: WHO; 2004. http://www.whqlibdoc.who.int/
Harmark L, van Grootheest AC. Pharmacovigilance: Methods, recent developments and future perspectives. Eur J Clin Pharmacol 2008;64:743-52.
World Health Organization. Safety of medicines: pharmacovigilance programme of India. WHO Drug Information. 2018;32(1):10-7.
Jeetu G, Anusha G. Pharmacovigilance: a worldwide master key for drug safety monitoring. Journal of Young Pharmacists. 2010 Jul 1;2(3):315-20.
Braveman P, Gottlieb L. The social determinants of health: it’s time to consider the causes of the causes. Public Health Rep. 2014; 129 Suppl 2(Suppl 2):19-31.
Munshi R, Maurya M, Pawaskar P. Public Awareness and Perception About Drug Safety in the Population Residing in Western India - A Questionnaire Based Cross Sectional Survey. Biomed Pharmacol J 2022;15(4).
Suke SG, Kosta P, Negi H. Role of Pharmacovigilance in India: An overview. Online J Public Health Inform. 2015 1;7(2): e223.
Patel JJ, Shah MK, Patel PP, Gandhi AM, Desai MK. Knowledge, attitude and practice among consumers about adverse drug reaction reporting. International Journal of Basic & Clinical Pharmacology. 2019 Jul 23;8(8):1776.
Thadani A, Abidi A, Qadeer F, Bhagchandani D, Hasan R, Rizvi D. Evaluation of knowledge and awareness of adverse drug reaction reporting among patients visiting a tertiary care hospital in northern India. Asian Journal of Pharmacy and Pharmacology. 2019 Jan;5(2):310-5.
Pahuja R, Shrivastava B, Sharma P K, Kishore K, Mahajan S & Sood R. 2014. Awareness on adverse drug reaction reporting system in India: a consumer survey American Journal of Phytomedicine and Clinical Therapeutics 2(12):1361–1369
Kadhim, Kadhim. (2015). Self-Reporting of Adverse Drug Reactions in Iraqi Hospitals: Patient’s Perspectives. Pharmacology & Pharmacy. 06. 566-572. 10.4236/pp.2015.612058.
Mohammad A, Bheemavarapu H, Khan MU, Khan A, Ahmad A, Hassali MA, Blebil AQ. A cross‐sectional survey to assess the knowledge, attitudes and common barriers to the reporting of adverse drug reactions by the general public in Malaysia. Journal of Pharmacy Practice and Research. 2018 Aug;48(4):348-55.
van Hunsel F, Härmark L, Pal S, Olsson S, van Grootheest K. Experiences with adverse drug reaction reporting by patients: an 11-country survey. Drug Saf. 2012 Jan 1;35(1):45-60. doi: 10.2165/11594320-000000000-00000. PMID: 22149419.
Kitabayashi A, Inoue Y. Factors that Lead to Stagnation in Direct Patient Reporting of Adverse Drug Reactions: An Opinion Survey of the General Public and Physicians in Japan. Therapeutic Innovation & Regulatory Science. 2022 Jul;56(4):616-24.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Kartiki Aher, Smita A Tiwari, Prerana M Kadam
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
https://creativecommons.org/licenses/by-nc/2.0/deed.en